@FiercePharma: Baxter to put $300M into old Genmab plant in Minnesota. More | Follow @FiercePharma
@EricPFierce: Is your company among the top 10 pharma companies by employees? If so, where does it fall? Story | Follow @EricPFierce
> Production problems at a contract manufacturer will put GlaxoSmithKline's ($GSK) restless legs drug Horizant in short supply till June. Report
> Baxter International's ($BAX) first-quarter earnings dropped on acquisition costs to $552 million, as its pharma-partnering sales suffered. Release | Report
> South Africa's Aspen Pharmacare plans to buy Nestle's nutrition business in the country for $215 million. Report
> Elan ($ELN) bought back $1 billion of its shares at $11.25 each, automatically depressing Royalty Pharma's $7.3 billion takeover offer. Report
> The GAVI Alliance made a deal with India's Biological E to supply a pentavalent childhood vaccine at a price of $1.19 per dose, almost $1-per-shot lower than the weighted average price last year. Report
@FierceMedDev: Combat Medical Systems wins $86M govt. contract. Story | Follow @FierceMedDev
@MarkHFierce: Dx development for the developing world is a hot new area, and the U.K.'s Lumora is diving in. More | Follow @MarkHFierce
@DamianFierce: Abbott won FDA approval for a new eye implant, part of its efforts to boost sluggish medical device sales. News | Follow @DamianFierce
> EU faulty implant trial gets colorful amid patients' jeers. Story
> Illumina reaches into China with diagnostics partnership. Item
> Baxter infusion pump, dialysis sales rise slowly. More
Biotech News
@FierceBiotech: GlaxoSmithKline picks up FDA panel plug for Breo approval. Story | Follow @FierceBiotech
@RyanMFierce: S. Korean biotech Celltrion "drops" late-stage Rituxan biosim. Can you imagine this happening w/ a s. molecule? Nope. Report | Follow @RyanMFierce
> Abbott aids biotech Epizyme in matching epigenetic drug with cancer patients. More
> Roche sees another Rituxan biosimilar trial bite the dust. Article
> Antibiotics upstart Allecra snags €15M VC round amid superbug scare. More
Vaccines News
> H7N9 cases jump, some show resistance to Roche's Tamiflu. More
> Polio eradication push nearing endgame again. Story
> ITS eyes Big Pharma suitors as universal flu vaccine advances. Article
> India's Biological E pentavalent vaccine takes on GSK, J&J. Item
> Vaccine campaign struggling to contain measles outbreak. More
Pharma Manufacturing News
> Issues with contractor leads to shortage of GSK's Horizant. More
> Sanofi expands in Morocco with €20M hub. News
> Canada's Pharmascience opens new distribution center. Story
> Hikma will keep injectables manufacturing. More
> Contaminated capsules dissolve Biostar earnings. Article
And Finally... Fame and achievement in performance-related careers may be earned at the cost of a shorter life, a study found. Report